Valanafusp alfa

• Target :

  IGF-1R

• Related Pathways :

  Tyrosine Kinase/Adaptors

• Bioactivity :

  Valanafusp alfa (AGT-181) is a recombinant fusion protein combining a chimeric monoclonal antibody targeting the human insulin receptor (HIR) with human iduronidase (IDUA), facilitating brain penetration, and is utilized in researching Mucopolysaccharidosis type I (MPS I) [1].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  1815583-32-4